Antidiabetic and antihyperlipidemic activities of a novel polyherbal formulation in high fat diet/streptozotocin induced diabetic rat model

Keyphrases

• High-fat Diet 100%
• Diabetic Mouse Model 100%
• Streptozotocin-induced Diabetic Rats 100%
• Antidiabetic Activity 100%
• Polyherbal Formulation 100%
• Antihyperlipidemic Activity 100%
• Diabetic Rats 42%
• Metformin 42%
• Blood Glucose 28%
• Gluconeogenic Enzymes 28%
• Pancreas 14%
• Liver 14%
• Diabetic 14%
• Kidney 14%
• Streptozotocin 14%
• Diabetes Complications 14%
• Drug-treated 14%
• Days of Treatment 14%
• Non-diabetic 14%
• Histopathological Changes 14%
• Oral Dose 14%
• Oral Administration 14%
• Plasma Lipids 14%
• Histological Examination 14%
• Organ Tissue 14%
• Lipid Profile 14%
• Antihyperglycemic 14%
• Plasma Glucose 14%
• Glucose Profile 14%
• Diabetic Control 14%
• Glucometer 14%
• Tissue Changes 14%
• Blood Changes 14%
• Antihyperlipidemic 14%
• Lipid Profile Levels 14%
• Rat Organs 14%
• Hydroalcoholic Extract 14%
• Parviflora 14%
• Garcinia Indica 14%
• Salacia Oblonga 14%
• Salacia 14%
• Blood Glucose Test Strips 14%
• Diabetic Drugs 14%
• Lagerstroemia 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Diabetes Mellitus 100%
• Rat Model 100%
• Antidiabetic Agent 100%
• Streptozotocin 100%
• Antihyperlipidemic Activity 100%
• Metformin 60%
• Salacia 40%
• Antilipemic Agent 20%
• Garcinia 20%
• Lagerstroemia 20%

Biochemistry, Genetics and Molecular Biology

• Rat Model 100%
• Streptozotocin 100%
• Glucose Blood Level 75%
• Enzyme 50%
• Lipid Profile 50%
• Salacia 50%
• Extract 25%
• Low Drug Dose 25%
• Body Weight 25%
• Glucose Test 25%
• Glucose Tolerance Test 25%
• Lagerstroemia 25%
• Garcinia 25%